Anita Fereshetian RPh, MS
Director, Regulatory Strategy
Anita Fereshetian has over twenty years of experience in drug development from trial design to NDA submission, including protocol planning and execution, study data interpretation and analysis, safety and risk management, and worldwide regulatory strategy. Anita has held positions of increasing levels of responsibility at two major pharmaceutical companies and one small biotech firm. In these roles she has provided regulatory guidance and strategic direction to project teams both locally and internationally. Her experience includes broad therapeutic area expertise in oncology, cardiovascular medicine, gastrointestinal, atherosclerosis, metabolic diseases, diabetes, pain, osteoporosis, and women’s health.
Anita attended the University of Michigan, earning a BS in Psychology and an MS in Clinical Research Design and Statistical Analysis. She is a registered pharmacist having graduated from the University of Utah and completing a residency in hospital pharmacy at Harper-Grace Hospitals in Detroit, Michigan.